In this episode, Anousha is joined by Dr. Su Wang, Medical Director of the Chinese Medical Program at Cooperman Barnabas Medical Center and Medical Advisor to the Hepatitis B Foundation, along with Dr. Thomas Tu, Molecular Biologist at the Westmead Institute for Medical Research in Australia. Together, they discuss expanding hepatitis B treatment guidelines by broadening eligibility criteria, improving access, reducing loss to follow-up, and the importance of including public health and patie...
All content for B Heppy is the property of Hepatitis B Foundation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Anousha is joined by Dr. Su Wang, Medical Director of the Chinese Medical Program at Cooperman Barnabas Medical Center and Medical Advisor to the Hepatitis B Foundation, along with Dr. Thomas Tu, Molecular Biologist at the Westmead Institute for Medical Research in Australia. Together, they discuss expanding hepatitis B treatment guidelines by broadening eligibility criteria, improving access, reducing loss to follow-up, and the importance of including public health and patie...
Updated CDC Guidelines on Hepatitis B Screening and Vaccination with Dr. Chari Cohen and Dr. Carolyn Wester.
B Heppy
29 minutes
1 year ago
Updated CDC Guidelines on Hepatitis B Screening and Vaccination with Dr. Chari Cohen and Dr. Carolyn Wester.
In this episode, Bright and Anousha interviewed Dr. Chari Cohen (President of the Hepatitis B Foundation), and Dr. Carolyn Wester (Director of the Division of Viral Hepatitis at the CDC). Dr. Cohen and Dr. Wester shared insights about the importance and impact of the universal hepatitis B screening and vaccination recommendations for adults in the United States. Check out additional resources by the CDC on hepatitis B vaccination and screening recommendations.Hepatitis B - Vaccination of...
B Heppy
In this episode, Anousha is joined by Dr. Su Wang, Medical Director of the Chinese Medical Program at Cooperman Barnabas Medical Center and Medical Advisor to the Hepatitis B Foundation, along with Dr. Thomas Tu, Molecular Biologist at the Westmead Institute for Medical Research in Australia. Together, they discuss expanding hepatitis B treatment guidelines by broadening eligibility criteria, improving access, reducing loss to follow-up, and the importance of including public health and patie...
